NICE to assess Siemens' Clinitek Microalbumin 9 renal disease test strips
This article was originally published in Clinica
Executive Summary
The UK’s National Institute for Health and Clinical Excellence (NICE) is to evaluate Siemens’ Clinitek Microalbumin 9 urinalysis reagent strips for use in the early detection and monitoring of kidney disease. The product, which is marketed by Siemens Healthcare Diagnostics, based in Tarrytown, New York, will be assessed under the institute's medical technologies evaluation pathway (MTEP). All dates for the project have yet to be announced, but NICE is inviting stakeholders to register their interest in becoming involved in the assessment. The Clinitek urinalysis strips test for albumin, blood, creatinine, glucose, ketone, leukocyte, nitrite, pH and protein, and boasts automatic calculation of albumin-to-creatinine and protein-to-creatinine ratios.